- 4.9Impact Factor
- 9.0CiteScore
- 21 daysTime to First Decision
Current Progress in Neutrophil Extracellular Traps (NETs)
This special issue belongs to the section “Molecular Immunology“.
Special Issue Information
Dear Colleagues,
Neutrophil extracellular traps (NETs) are increasingly recognized as key regulators of immune function, possessing a dual role. While their physiological formation by activated neutrophils supports innate immunity by trapping and neutralizing pathogens, excessive NET production and impaired clearance contribute to chronic inflammation and tissue damage. NETs are implicated in the pathogenesis of autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, and psoriasis, where autoantibodies frequently target NET components and the histone-modifying enzyme peptidylarginine deiminase (PAD4). PAD4 and PAD2 have also emerged as novel autoantigens, expanding the scope of autoimmune mechanisms. Novel cancer research highlights NET-like structures known as Cellular Extrachromatin Cancer Networks (CECNs). Dependent on PAD4, these structures promote tumor heterogeneity, treatment resistance, and metastasis through non-canonical intercellular communication and adaptation to microenvironmental stress, revealing a new dimension in tumor biology.
We invite authors to submit manuscripts in the following areas:
- General reviews on NETs, providing biological background;
- Original research articles based on clinical data;
- Studies on PAD2/PAD4 as autoantigens, elucidating autoimmune mechanisms;
- Publications on NETs in oncology / CECNs, representing a novel research direction;
- Methodological papers describing techniques for NET detection;
- Articles on targeted therapies, allowing for clinically relevant conclusions.
Dr. Joanna Czerwińska
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- PAD4
- NETs
- autoimmune diseases
- CECNs
- autoantibodies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

